Epacria Capital Partners’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Hold
290,381
13.84% 1
2026
Q1
$17M Sell
290,381
-25,150
-8% -$1.49M 13.15% 2
2025
Q4
$17.9M Hold
315,531
14.15% 1
2025
Q3
$16.7M Hold
315,531
13.59% 2
2025
Q2
$14.9M Buy
315,531
+1,000
+0.3% +$44.3K 12.47% 2
2025
Q1
$13M Hold
314,531
10.59% 2
2024
Q4
$11.4M Hold
314,531
9.65% 2
2024
Q3
$11.5M Hold
314,531
7.85% 4
2024
Q2
$9.73M Buy
314,531
+2,800
+0.9% +$85K 7.13% 4
2024
Q1
$9.51M Buy
311,731
+10,900
+4% +$328K 6.89% 3
2023
Q4
$9.13M Buy
300,831
+2,650
+0.9% +$80.6K 7.31% 3
2023
Q3
$9.71M Sell
298,181
-6,600
-2% -$218K 8.04% 3
2023
Q2
$10.8M Buy
304,781
+1,108
+0.4% +$37.9K 8.87% 2
2023
Q1
$10.7M Buy
303,673
+45,144
+17% +$1.7M 8.28% 3
2022
Q4
$10.3M Buy
+258,529
New +$10.2M 8.14% 3

Other funds holding BTI

Epacria Capital Partners's BTI Position: Q2 2026 in Review

Epacria Capital Partners held its British American Tobacco (BTI) position steady in Q2 2026 at 290,381 shares worth $17.9M. The position accounts for 13.84% of the portfolio, ranked #1.

Epacria Capital Partners first reported a position in BTI in Q4 2022 and has held it in 15 quarters since. 904 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Epacria Capital Partners held 290,381 shares of British American Tobacco worth $17.9M as of Q2 2026.
  • Epacria Capital Partners left its British American Tobacco share count unchanged in Q2 2026.
  • British American Tobacco made up 13.84% of Epacria Capital Partners's portfolio in Q2 2026, its #1 holding.
  • Epacria Capital Partners first reported a position in British American Tobacco in Q4 2022 and has held it in 15 quarters since.
  • 904 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Epacria Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.